Oropouche virus

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Orthobunyavirus
Virus classification
Group: Group V ((-)ssRNA)
Order: Unassigned
Family: Bunyaviridae
Genus: Orthobunyavirus
Species: Oropouche virus

The Oropouche virus (OROV) is one of the most common orthobunyaviruses. When OROV infects humans, it causes a rapid fever illness called Oropouche fever. OROV was originally reported in Trinidad and Tobago in 1955 from the blood sample of a fever patient and from a pool of Coquillettidia venezuelensis mosquitoes. In 1960, OROV was isolated from a sloth (Bradypus tridactylus) and a pool of Ochlerotatus (Ochlerotatus) serratus mosquitoes in Brazil.[1] The virus is considered a public health threat in tropical and subtropical areas of Central and South America, with over half million infected people as of 2005.[2] OROV is considered to be an arbovirus due to the method of transmission by the mosquitoes Aedes serratus and Culex quinquefasciatus among sloths, marsupials, primates, and birds.[3]

Epidemic Sites[edit]

Between 1961 to 1980, OROV was reported in the northern state of Pará, Brazil, and from 1980 to 2004, OROV had spread to the Amazonas, Amapá, Acre, Rondônia, Tocantis, and Maranhão.[2] The virus would cause Oropouche fever, an urban arboviral disease that has since resulted in >30 epidemics during 1960-2009.[4]

Virology[edit]

Currently, there are 4 major genotypes (I-IV) of OROV. Genotype I was isolated from strains in Acre, Amazonas, Maranhão, Tocantis, Pará, Trinidad, and Tobago. Genotype II was obtained during the spread in Amapá, Pará, Rondônia, and Peru. Genotype III was isolated from samples in Acre, Minas Gerais, Panama, and Rondônia. The final genotype IV was isolated from Amazonas.[1]

Dispersion[edit]

A possible dispersal could be predicted for the four genotypes based on time-scaled analysis and epidemiologic data association. Genotype I possibly dispersed towards western Pará, Trinidad, and Tobago. After, genotype I progressed towards Amazonas, Acre, Maranhao, and Tocantins. Genotype II possibly emerged in Amapá, Pará, Rondônia, and Peru at the same time. Genotype III emerged in Rondônia, moved towards Panama, Acre, and Maranhão. From Maranhão, the genotype progressed towards Minas Gerais. Finally, genotype IV emerged from the city of Manaus and Amazonas.[4]

Experimentation and Research[edit]

OROV has been used extensively in testing with Hela cells to study the mechanisms of apoptosis induced by the virus. It was found that OROV causes apoptosis by DNA fragmentation. In UV-inactivated OROV, virus-receptor binding was not enough and that viral uncoating and replication were needed to induce apoptosis.[5]

References[edit]

  1. ^ a b Vasconcelos, Helena Baldez; Nunes, Márcio R.T.; Casseb, Lívia M.N.; Carvalho, Valéria L.; Pinto da Silva, Eliana V.; Silva, Mayra; Casseb, Samir M.M.; Vasconcelos, Pedro F.C. (2011). "Molecular Epidemiology of Oropouche Virus, Brazil". Emerging Infectious Diseases 17 (5): 800–806. doi:10.3201/eid1705.101333. ISSN 1080-6040. 
  2. ^ a b Nunes, Marcio Roberto Teixeira; Et Al (2005). "Oropouche virus isolation, southeast Brazil". Emerging Infectious Diseases (PDF) 11 (10): 1610–1613. doi:10.3201/eid1110.050464. 
  3. ^ Mourao, Maria Paula G.; Et Al (2009). "Oropouche Fever Outbreak, Manaus, Brazil, 2007-2008". Emerging Infectious Diseases (PDF) 15 (12): 2063–2064. doi:10.3201/eid1512.090917. 
  4. ^ a b "Molecular Epidemiology of Oropouche Virus, Brazil". Retrieved 2013-04-08. 
  5. ^ Acrani, Gustavo Olszanski; Gomes, Rogério; Proença-Módena, José Luiz; da Silva, Andrei Furlan; Oliveira Carminati, Patricia; Silva, Maria Lucia; Santos, Rodrigo Ivo Marques; Arruda, Eurico (2010). "Apoptosis induced by Oropouche virus infection in HeLa cells is dependent on virus protein expression". Virus Research 149 (1): 56–63. doi:10.1016/j.virusres.2009.12.013. ISSN 0168-1702. PMID 20080135.